Gepants — a long way to cure: a narrative review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10072-022-06184-8.pdf
Reference75 articles.
1. Ashina M, Katsarava Z, Do TP et al (2021) Migraine: epidemiology and systems of care. Lancet 397:1485–1495. https://doi.org/10.1016/S0140-6736(20)32160-7
2. Buse DC, Fanning KM, Reed ML et al (2019) Life with migraine: effects on relationships, career, and finances from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache 59:1286–1299. https://doi.org/10.1111/head.13613
3. Evers S, Áfra J, Frese A et al (2009) EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol 16:968–981. https://doi.org/10.1111/j.1468-1331.2009.02748.x
4. Hepp Z, Dodick DW, Varon SF et al (2017) Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia 37:470–485. https://doi.org/10.1177/0333102416678382
5. Altamura C, Corbelli I, de Tommaso M et al (2021) Pathophysiological bases of comorbidity in migraine. Front Hum Neurosci 15:640574. https://doi.org/10.3389/fnhum.2021.640574
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study;The Journal of Headache and Pain;2024-02-02
2. Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE);Neurology and Therapy;2024-01-19
3. Migraine Comorbidities;Life;2024-01-02
4. Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection – A Narrative Review;Therapeutics and Clinical Risk Management;2023-11
5. Gepants in the acute management of migraine;Pain Management;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3